Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$102.72 USD

102.72
7,656,647

-0.24 (-0.23%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $102.67 -0.05 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

LabCorp Diagnostics Strong on Novant Health Deal Extension

Laboratory Corporation of America Holdings (LH), also referred to as LabCorp, has decided to extend its Technical Services Agreement with Novant Health which was originated in 2012.

    Medtronic (MDT) Launches Resolute Onyx DES Device in Japan

    Medtronic plc (MDT), a leading global player in medical technology, services and solutions, is set to make another encouraging move with respect to its highest revenue grossing Cardiovascular segment.

      Thermo Fisher at a 52-Week High: What's Driving the Stock?

      Share price of Thermo Fisher Scientific Inc. (TMO), headquartered in Waltham, MA, scaled a new 52-week high of $177.99 on Jul 7, eventually closing a shade lower at $177.49.

        Investors Look for Gains as Abbott Labs Set to Acquire Alere

        On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.

          Phibro Animal Health & Zydus Cadila Plan to Expand in India

          Phibro Animal Health Corporation (PAHC) recently announced plans to enter into a long-term agreement with global pharmaceutical company Zydus Cadila to expand in the rapidly growing poultry market in India.

            Exactech Boosts Knee System Portfolio, Launches New App

            Exactech, Inc.(EXAC) took a step towards it's goal of providing an all-inclusive range of knee replacement systems with the launch of ExactechGPS TKA PLUS.

              Here's Why You Should Add Abbott Laboratories Right Now

              Illinois-based global medical device company Abbott Laboratories (ABT) has been gaining investor confidence on consistent positive results

                Abbott Freestyle Libre System Gets Health Canada License

                Abbott Laboratories (ABT) recently announced the receipt of Health Canada license for its FreeStyle Libre Flash Glucose Monitoring System.

                  Jeffrey Hymen headshot

                  5 Underfollowed Stocks That Are Projected To Explode

                  These stocks represent a few investments that could possibly turn out to be hidden gems.

                    2 Solid Medical Device Stocks to Scoop Up Right Away

                    Let's focus on two medical device stocks which will make valuable additions to an investment portfolio in the wake of widespread volatility in the medical device market.

                      The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores

                      The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores

                        Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak

                        On Jun 14, we issued an updated research report on Illinois-based Abbott Laboratories (ABT). It is a leading distributor of health care products and services across the globe.

                          Abbott Laboratories at 52-Week High on Product Line, Buyouts

                          Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.

                            The Zacks Analyst Blog Highlights: Alphabet, Morgan Stanley, Abbott, Waste Management, General Mills and Raytheon

                            The Zacks Analyst Blog Highlights: Alphabet, Morgan Stanley, Abbott, Waste Management, General Mills and Raytheon

                              Abbott Labs (ABT) Down 2.3% Since Earnings Report: Can It Rebound?

                              Abbott Labs (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec

                                The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec

                                  Abbott Lab Well Poised on Strong EPD, St. Jude Integration

                                  On May 17, we issued an updated research report on Abbott Laboratories (ABT).

                                    Company News for April 20, 2017

                                    Companies in the News are: LRCX,FB,RARE,ABT

                                      Sheraz Mian headshot

                                      Q1 Scorecard & Stock Research Reports for IBM, Abbott and others

                                      Today's Research Daily features new research reports on 16 major stocks, including IBM (IBM), Abbott (ABT) and Dow Chemical (DOW).

                                        Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device

                                        Abbott Laboratories (ABT) reported first-quarter 2017 adjusted earnings from continuing operations of 48 cents per share, up 17.1% year over year.

                                          Abbott Laboratories (ABT) Tops Q1 Earnings & Sales Estimates

                                          Currently, Abbott Labs has a Zacks Rank #3 (Hold), but that could definitely change following the company's first quarter 2017 earnings report which was just released.

                                            Company News for April 18, 2017

                                            Companies in the News are: MGI,LLY,ASH,ALR,ABT

                                              Company News for April 17, 2017

                                              Companies in the News are: ABT,UAL,GS,PIR

                                                Abbott Laboratories Agrees to Acquire Alere at Lower Price

                                                Abbott has agreed to pay $51 per common share to acquire Alere, a reduction from earlier deal of $56 per common share upon the completion of the transaction.

                                                  Will Abbott Lab (ABT) Surprise Estimates in Q1 Earnings?

                                                  Abbott Laboratories (ABT) is scheduled to report first-quarter 2017 results before the opening bell on Apr 19.